QA: Verona Pharma plc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001657312_2024_Verona_Pharma_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001657312, Verona Pharma plc

  xvar xval
0 AssetsCurrent 289,708,000
1 IntangibleAssetsNetIncludingGoodwill 545,000
2 PropertyPlantAndEquipmentNet 24,000
3 remainder_Assets 17,847,000
4 LiabilitiesCurrent 8,692,000
5 LiabilitiesNoncurrent 50,149,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 337,754
8 SellingGeneralAndAdministrativeExpense 48,489,546
9 ResearchAndDevelopmentExpense -521,826
10 remainder_Expenses 459,572
11 remainder_Revenues 155,957
12 remainder_NetIncome 12,254,118
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 308,124,000
1 Liabilities 58,841,000
2 Expenses 48,765,046
3 Revenues 155,957
4 StockholdersEquity 249,283,000
5 NetIncome -36,354,971
6 ComprehensiveNetIncome -36,354,971
7 BaseVar 214,070,060
8 EconomicCapitalRatiobeforeLimitedLiability 2.76
9 EconomicCapitalRatio 3.53

Edgar->Model Mapping

Feature Distribution

Change over Time